POST Online Media Lite Edition



 

NEWLY REPORTED COVID-19 CASES IN LAST 24 HOURS (9.24.2021, 6:35pm CEST, WHO):   U.S. 121,396    India 31,382    Brazil 36,473    United Kingdom 35,764    Russia 21,379    Turkey 27,844    France 5,433    Argentina 2,034    Columbia 1,581    Spain 1,056    Italy 4,053    Indonesia 2,557    Germany 9,727    Mexico 11,603    South Africa 2,783    Philippines 17,411    Ukraine 9,058    Malaysia 13,754    Netherlands 1,841    Iraq 2,953    Japan 3,457    Canada 3,870    Bangladesh 1,233    Thailand 12,697    Israel 6,314    Pakistan 2,357    Romania 7,116    Serbia 6,480    Cuba 6,935    Nepal 1,103    Vietnam 9,472    Austria 1,708    Greece 2,101    Georgia 1,698    Belarus 1,973    Costa Rica 2,547    Bulgaria 1,835    Azerbaijan 1,178    Myanmar 1,667    Croatia 1,291    Ireland 1,354    Venezuela 1,140    Ethiopia 1,544    Libya 1,006    Lithuania 1,477    South Korea 2,434    Mongolia 2,612    Slovenia 1,011    Moldova 1,215    Botswana 2,639    New Caledonia 1,078    China 65    Singapore 1,504    New Zealand 10    Australia 1,850   

Denmark suspends AstraZeneca COVID-19 vaccine for another three weeks

Christian Fernsby |
The Danish Health Authority put vaccination with the COVID-19 vaccine from AstraZeneca on hold on 11 March 2021 following reports of several severe cases of blood clots, decrease in platelet count and bleeding.

Article continues below




Subsequently, the European Medicines Agency (EMA) has analysed 25 cases of these and similar types of severe and rare side effects.

On 18 March 2021, a preliminary review from the EMA concluded that the COVID-19 vaccine from AstraZeneca might be associated with the occurrence of rare but severe cases of blood clots.

"We have launched several independent studies and consulted relevant experts. We are confident that we will be able to uncover the extent and possible correlation between the side effects and the vaccine and, combined with reviews and conclusions from the EMA, we will have a solid foundation on which to make our final decision on using the vaccine from AstraZeneca", says Director General Søren Brostrøm.

The Danish Health Authority continuously receives feedback and results of the ongoing studies, but it is still too early to draw any definitive conclusions.

"At this time, we believe that our basis for making a final decision on any future use of the COVID-19 vaccine from AstraZeneca is too uncertain. Many studies have been initiated, but we do not yet have any conclusions. Therefore, the hold on using the vaccine remains in effect," says Director General Søren Brostrøm.

The consequence of the extended hold on the vaccine for another three weeks is that any bookings for the first or second injection with the AstraZeneca vaccine will be cancelled. Furthermore, those who have already been invited to vaccination with AstraZeneca – and who would otherwise have been given the first injection in the coming weeks – will have to wait a little longer.

"We are very conscious that a continued hold on vaccination with the COVID-19 vaccine from AstraZeneca delays the Danish vaccination programme against COVID-19. However, the vaccines are already in the refrigerator. If we decide to recommence vaccination with the COVID-19 vaccine from AstraZeneca, we can quickly distribute and use the vaccines," says Søren Brostrøm.

The Danish Health Authority will make its final decision on the COVID-19 vaccine from AstraZeneca in week 15.


What to read next

Romania and Thailand suspends AstraZeneca vaccine, Germany and France not worried
New vaccine to provide 2-year protection
Moderna begins testing next-generation coronavirus vaccine